繁體中文
返回
- English
- 繁體中文
- 简体中文
- 深色
- 淺色
立即開戶
Veeva Systems | 10-Q: Q3 2025 Earnings Report
Veeva Systems | 10-Q: Q3 2025 Earnings Report
Veeva Systems | 10-Q:2025財年三季報
牛牛AI助理已提取核心訊息
Veeva Systems, the leading provider of industry cloud solutions for the global life sciences industry, reported total revenues of $2,364 million for the fiscal year ended January 31, 2024, representing a 10% year-over-year growth. Subscription services revenues increased by 10% to $1,902 million, while net income rose to $526 million from $488 million in the previous year.The company's offerings span cloud software, data, and business consulting, designed to meet the unique needs of life sciences customers. Veeva's solutions are grouped into three major product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. For the fiscal year 2024, Commercial Solutions and R&D Solutions each contributed approximately 50% to total revenues.As of January 31, 2024, Veeva served 1,432 customers, up from 1,388 in the previous year. The company expects revenues associated with R&D Solutions to increase as a percentage of both subscription services revenues and total revenues in the future. Veeva continues to expand its reach, offering certain R&D Solutions to industries outside life sciences, primarily in North America and Europe.
Veeva Systems, the leading provider of industry cloud solutions for the global life sciences industry, reported total revenues of $2,364 million for the fiscal year ended January 31, 2024, representing a 10% year-over-year growth. Subscription services revenues increased by 10% to $1,902 million, while net income rose to $526 million from $488 million in the previous year.The company's offerings span cloud software, data, and business consulting, designed to meet the unique needs of life sciences customers. Veeva's solutions are grouped into three major product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. For the fiscal year 2024, Commercial Solutions and R&D Solutions each contributed approximately 50% to total revenues.As of January 31, 2024, Veeva served 1,432 customers, up from 1,388 in the previous year. The company expects revenues associated with R&D Solutions to increase as a percentage of both subscription services revenues and total revenues in the future. Veeva continues to expand its reach, offering certain R&D Solutions to industries outside life sciences, primarily in North America and Europe.
Veeva Systems作爲全球生命科學行業領先的行業雲解決方案提供商,報告截至2024年1月31日財年的總收入爲236400萬美元,同比增長10%。訂閱服務收入增長了10%,達到190200萬美元,而淨利潤從上年的48800萬美元上升至52600萬美元。公司的產品涵蓋雲軟件、數據和業務諮詢,旨在滿足生命科學客戶的獨特需求。Veeva的解決方案分爲三個主要產品類別:Veeva開發雲、Veeva商業雲和Veeva數據雲。在2024財年,商業解決方案和研發解決方案各自約貢獻了50%的總收入。截至2024年1月31日,Veeva服務了1432個客戶,較上年的1388個有所增加。公司預計未來與研發解決方案相關的收入將在訂閱服務收入和總收入中佔比提高。Veeva繼續擴大其業務範圍,將某些研發解決方案提供給生命科學以外的行業,主要在北美和歐洲。
Veeva Systems作爲全球生命科學行業領先的行業雲解決方案提供商,報告截至2024年1月31日財年的總收入爲236400萬美元,同比增長10%。訂閱服務收入增長了10%,達到190200萬美元,而淨利潤從上年的48800萬美元上升至52600萬美元。公司的產品涵蓋雲軟件、數據和業務諮詢,旨在滿足生命科學客戶的獨特需求。Veeva的解決方案分爲三個主要產品類別:Veeva開發雲、Veeva商業雲和Veeva數據雲。在2024財年,商業解決方案和研發解決方案各自約貢獻了50%的總收入。截至2024年1月31日,Veeva服務了1432個客戶,較上年的1388個有所增加。公司預計未來與研發解決方案相關的收入將在訂閱服務收入和總收入中佔比提高。Veeva繼續擴大其業務範圍,將某些研發解決方案提供給生命科學以外的行業,主要在北美和歐洲。
有用
沒用
譯文內容由第三人軟體翻譯。
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
風險及免責聲明
牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
我知道了
資訊熱榜
更新時間